A Prevalence Study of Obstructive Sleep Apnea in Subjects With Chest Pain, Positive Exercise Treadmill Test and Normal Coronary Angiogram
- Conditions
- Obstructive Sleep ApneaCardiac Syndrome XEndothelial Dysfunction
- Interventions
- Other: no intervention is involved in this study
- Registration Number
- NCT01217346
- Lead Sponsor
- The University of Hong Kong
- Brief Summary
Cardiac syndrome X consists of a triad of chest pain, abnormal exercise stress testing and normal coronary angiogram, and is hypothesized to be related to endothelial dysfunction. Endothelial dysfunction is also reported to be linked to obstructive sleep apnea. While chest pain can be one of potential presenting symptoms of obstructive sleep apnea, the investigators hypothesize that obstructive sleep apnea is common in subjects with cardiac syndrome X.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 20
- Age ≧18 years, < 70 years
- Symptom of chest pain occurring at least once in the preceding year
- Positive exercise treadmill test
- Negative coronary angiogram
- Mentally fit to give informed consent
- Mentally incapacitated persons
- Congestive heart failure
- Other potential causes of orthopnea (severe chronic obstructive pulmonary disease, persistent asthma)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description cardiac syndrome X no intervention is involved in this study subjects fulfilling the clinical triad of cardiac syndrome X
- Primary Outcome Measures
Name Time Method apnea hypopnea index measure at a single time point when the subjects are admitted for overnight polysomnography assess apnea hypopnea index by overnight polysomnography, by a single admission to sleep laboratory
- Secondary Outcome Measures
Name Time Method endothelial function measured at a single time point when the subjects are admitted for overnight polysomnography assess endothelial function by EndoPAT 2000 (an non-invasive device) and peripheral blood endothelial progenitor cells
Trial Locations
- Locations (1)
Queen Mary Hospital, The University of Hong Kong
🇭🇰Hong Kong, Hong Kong